P-5 Defining Irreversible Pulpitis in the Age of Tricalcium Silicates

5 (3 votes)

CE Hours: 1.5

Description: The advent of MTA and other tricalcium silicates, with their remarkable biocompatibility and stability, has renewed the interest in vital pulp therapy approaches. These therapies have challenged the classic definition of irreversible pulpitis. This panel presentation will review available data on the clinical and histologic diagnosis of irreversible pulpitis and will discuss recent evidence that support vital pulp therapy in permanent mature teeth.

  • Explain the clinical and histologic evidence for the diagnosis of irreversible pulpitis.
  • Distinguish between symptomatic and asymptomatic irreversible pulpitis.
  • Describe recent evidence that supports vital pulp therapy in mature permanent teeth diagnosed with reversible or irreversible pulpitis.

Key:

Complete
Failed
Available
Locked
Video
Open to view video.
Evaluation
9 Questions
CE Test
5 Questions  |  Unlimited attempts  |  4/5 points to pass
5 Questions  |  Unlimited attempts  |  4/5 points to pass
Certificate
1.50 CE credits  |  Certificate available
1.50 CE credits  |  Certificate available

Ashraf F. Fouad, D.D.S., M.S.

Dr. Fouad obtained his DDS, Certificate of Endodontics and MS at the University of Iowa. 

He served on the faculty and in various administrative roles at University of Connecticut, the University of Maryland, and the University of North Carolina at Chapel Hill. He is currently Professor and Chair, Department of Endodontics, Director, Advanced Endodontics Program, and Interim Director, Health Information and Business Systems (HIBS) at the University of Alabama at Birmingham.

Dr. Fouad has published over 110 peer-reviewed manuscripts, 25 textbook chapters, and 145 abstracts. He edited and co-authored the textbooks: Endodontic Microbiology (now in its second edition), as well as the fifth and sixth editions of Endodontics: Principles and Practice. He is a Diplomate and Past President of the American Board of Endodontics, and an Associate Editor of the Journal of Endodontics, Dental Traumatology and Frontiers of Dental Medicine – Endodontics. He received the Distinguished Scientist Award from the Pulp Biology and Regeneration Group of the International Association of Dental Research in 2017, and the AAE President’s Award in 2022.

Speaker Disclosure

I declare that I have no proprietary, financial, or other personal interest of any nature or kind in any product, service, course, and/or company, or in any firm beneficially associated therewith, that will be discussed or considered during the proposed presentation

Domenico Ricucci, M.D., D.D.S.

Dr. Domenico Ricucci received his degree in General Medicine from “La Sapienza” University of Rome in 1982, and his DDS from the same University in 1985. Since then on he has maintained private dental practices limited to endodontics. In addition to his private practice, Dr. Ricucci was Professor of Cariology at “Magna Graecia” University of Catanzaro, Italy in 2002 -2003. He served in the Research Committee of the European Society of Endodontology from 1999 to 2005. Dr. Ricucci’s primary research interest relates to pulpal and periapical tissue reactions to caries and treatment procedures, biofilms in endodontic infections, etiology of RTC treatment failure, pulp regeneration/revascularization. Since 1998 he has run his own histology laboratory and has developed considerable skills in hard tissue preparations for light microscopy. Dr. Ricucci has published 113 papers and has lectured both nationally and internationally. He has authored the Textbook and Atlas “Patologia e Clinica Endodontica”,  the textbook and atlas “Endodontology. An integrated biological and clinical view”, also translated into Chinese, Russian, Japanese. He has also authored or co-authored 22 book chapters.

Ashraf F. Fouad, D.D.S., M.S.
I declare that I have no proprietary, financial, or other personal interest of any nature or kind in any product, service, course, and/or company, or in any firm beneficially associated therewith, that will be discussed or considered during the proposed presentation.

Domenico Ricucci, D.D.S., MD
I declare that I have no proprietary, financial, or other personal interest of any nature or kind in any product, service, course, and/or company, or in any firm beneficially associated therewith, that will be discussed or considered during the proposed presentation.